Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;14(3):377-385.
doi: 10.4055/cios20312. Epub 2022 Feb 7.

Second-Look Arthroscopic Findings and Clinical Outcomes after Adipose-Derived Regenerative Cell Injection in Knee Osteoarthritis

Affiliations

Second-Look Arthroscopic Findings and Clinical Outcomes after Adipose-Derived Regenerative Cell Injection in Knee Osteoarthritis

Yuma Onoi et al. Clin Orthop Surg. 2022 Sep.

Abstract

Background: To evaluate the clinical outcomes and second-look arthroscopic findings after intra-articular adipose-derived regenerative cell (ADRC) injection as treatment for knee osteoarthritis (OA).

Methods: ADRCs were administered to 11 patients (19 knees; mean age, 61.7 years) with knee OA. Subcutaneous adipose tissue was harvested by liposuction from both thighs, and arthroscopic lavage was performed, followed by ADRC injection (mean dose, 1.40 × 107 cells) into the synovial fluid. Outcome measures included the Knee Injury and Osteoarthritis Outcome Score, Lysholm score, and visual analog scale score. Arthroscopic examinations were performed to assess the International Cartilage Repair Society cartilage injury grade preoperatively and overall repair postoperatively. Noninvasive assessments were performed at baseline and at 1-, 3-, and 6-month follow-ups; arthroscopic assessments were performed at baseline and at 6 months.

Results: All outcome measures significantly improved after treatment. This improvement was evident 1 month after treatment and was sustained until the 6-month follow-up. Data from second-look arthroscopy showed better repair in low-grade cartilage lesions than in lesions with a greater degree of damage. No patients demonstrated worsening of Kellgren-Lawrence grade, and none underwent total knee arthroplasty during this period.

Conclusions: Clinical outcomes were improved in patients with knee OA after ADRC administration. Cartilage regeneration was more effective in smaller damaged lesions than in bigger lesions.

Keywords: Adipose-derived regenerative cells; Cartilage disease; Knee osteoarthritis; Regenerative medicine; Second-look surgery.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST: No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1. Arthroscopic evaluation of articular cartilage regeneration in a case of International Cartilage Repair Society grade 1. (A) The preoperative cartilage injury area (arrow). (B) The lesion was completely covered by regenerated cartilage (arrow). This was scored as “normal” by second-look arthroscopy.
Fig. 2
Fig. 2. Arthroscopic evaluation of articular cartilage regeneration in a case of International Cartilage Repair Society grade 2. (A) The preoperative cartilage injury area (arrow). (B) The lesion was partially covered by regenerated cartilage and the cartilage defect area became smaller (arrow). This was scored as “nearly normal” by second-look arthroscopy.
Fig. 3
Fig. 3. Arthroscopic evaluation of articular cartilage regeneration in a case of International Cartilage Repair Society grade 3. (A) The preoperative cartilage injury area (arrow). (B) There was a little fibrillation but not enough regenerated cartilage (arrow). This was scored as “severely abnormal.”

References

    1. Buckwalter JA, Martin JA. Osteoarthritis. Adv Drug Deliv Rev. 2006;58(2):150–167. - PubMed
    1. Scanzello CR, Plaas A, Crow MK. Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? Curr Opin Rheumatol. 2008;20(5):565–572. - PubMed
    1. Coleman CM, Curtin C, Barry FP, O’Flatharta C, Murphy JM. Mesenchymal stem cells and osteoarthritis: remedy or accomplice? Hum Gene Ther. 2010;21(10):1239–1250. - PubMed
    1. Kesten S, Fraser JK. Autologous adipose derived regenerative cells: a platform for therapeutic applications. Surg Technol Int. 2016;29:38–44. - PubMed
    1. Lindroos B, Suuronen R, Miettinen S. The potential of adipose stem cells in regenerative medicine. Stem Cell Rev Rep. 2011;7(2):269–291. - PubMed